Treatment of Abdominal Necrotizing Fasciitis

Immediate Surgical Management

The American College of Surgeons recommends immediate aggressive surgical debridement combined with broad-spectrum antibiotics and hemodynamic support for abdominal necrotizing fasciitis, with return to the operating room every 24-36 hours until all necrotic tissue is removed 1
Surgical intervention is the primary therapeutic modality and must not be delayed for imaging or other diagnostic tests, as delay in diagnosis and treatment directly correlates with mortality and multi-organ failure 1, 2
The key surgical principles include performing immediate and aggressive debridement of all necrotic tissue as soon as necrotizing fasciitis is suspected, and returning to the operating room every 24-36 hours for repeat debridement until the surgical team determines no further necrotic tissue remains 1, 2

The Infectious Diseases Society of America recommends initiating broad-spectrum antibiotics immediately upon suspicion, before surgical intervention, with first-line regimens including vancomycin or linezolid plus piperacillin-tazobactam, vancomycin or linezolid plus a carbapenem, or vancomycin or linezolid plus ceftriaxone and metronidazole 1, 3
If Group A Streptococcus is documented, the Infectious Diseases Society of America recommends switching to penicillin plus clindamycin, as clindamycin inhibits toxin production even when bacterial growth has stopped 1, 3

The American College of Critical Care Medicine recommends administering aggressive intravenous fluid resuscitation, as these wounds discharge copious amounts of tissue fluid and patients frequently develop septic shock 1, 2
Adequate fluid resuscitation is as critical as surgical debridement for survival, and hemodynamic monitoring and vasopressor support should be provided as needed for septic shock 1, 2

The Infectious Diseases Society of America recommends continuing antibiotics until three criteria are met: no further surgical debridement is necessary, the patient has improved clinically, and the patient has been afebrile for 48-72 hours 1, 2
Typical total duration ranges from 2-3 weeks for deep soft tissue infections, though this should be individualized based on clinical response 1

The Infectious Diseases Society of America recommends transitioning to oral antibiotics guided by culture results, with options including linezolid, trimethoprim-sulfamethoxazole, or doxycycline for MRSA coverage, and penicillin V for streptococcal infections 1

The American College of Surgeons recommends definitive wound closure only after complete debridement of all necrotic tissue is achieved, the patient shows clinical improvement with 48-72 hours fever-free status, and ideally within 7 days of initial debridement once infection is controlled 2

The American College of Surgeons recommends never delaying surgical exploration while awaiting imaging results, never performing inadequate initial debridement, never using narrow-spectrum antibiotics, and never underestimating fluid requirements 1, 2

A multidisciplinary team including surgery, infectious diseases, and critical care is mandatory for optimal management, with attention to long-term reconstructive needs 1

The World Health Organization recommends administering linezolid 600 mg orally every 12 hours plus clindamycin 600-900 mg intravenously every 8 hours as part of empiric broad-spectrum therapy that also includes gram-negative and anaerobic coverage for adults with necrotizing fasciitis 4, 5
The Infectious Diseases Society of America suggests that linezolid plus clindamycin must be combined with anti-gram-negative and anti-anaerobic coverage 4, 5

The American College of Surgeons recommends the following complete empiric regimen options: linezolid 600 mg PO q12h PLUS piperacillin-tazobactam 3.375-4.5g IV q6-8h, linezolid 600 mg PO q12h PLUS a carbapenem, or linezolid 600 mg PO q12h PLUS ceftriaxone 2g IV q24h PLUS metronidazole 500mg IV q8h 5
Adding clindamycin 600-900 mg IV q8h to any of these regimens provides additional toxin suppression 5

The World Health Organization recommends linezolid as a preferred anti-MRSA agent over vancomycin in necrotizing fasciitis, particularly in patients with renal impairment 4, 6
Vancomycin should be avoided when the patient has renal impairment or when MRSA isolates show MIC ≥1.5 mg/mL 4, 6
Linezolid or daptomycin are drugs of choice for empirical anti-MRSA coverage 4, 6

The American College of Surgeons suggests that antibiotics are adjunctive to aggressive surgical management 4, 6
Delay in surgical intervention directly correlates with mortality and multi-organ failure 4, 6

The Infectious Diseases Society of America recommends never delaying surgical debridement while initiating antibiotics—surgery is the primary therapeutic modality 4, 6
Do not use narrow-spectrum antibiotics or monotherapy for empiric treatment 4, 6
Initial regimen must include anti-MRSA, anti-gram-negative, and anti-anaerobic coverage 4, 6